Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2019-12-23 4:00 pm Purchase | 13G | PROVENTION BIO INC PRVB | PERCEPTIVE ADVISORS LLC | 2,391,574 5% | 2,391,574 (New Position) | View |
| 2019-11-18 5:20 pm Purchase | 13G | AGILE THERAPEUTICS INC AGRX | PERCEPTIVE ADVISORS LLC | 11,919,925 18.5% | 5,008,524 (+72.47%) | View |
| 2019-11-15 6:05 pm Sale | 13G | DOVA PHARMACEUTICALS INC DOVA | PERCEPTIVE ADVISORS LLC | 0 0% | -3,125,851 (Position Closed) | View |
| 2019-10-30 4:30 pm Sale | 13G | AGILE THERAPEUTICS INC AGRX | PERCEPTIVE ADVISORS LLC | 6,911,401 11.7% | -1,515,349 (-17.98%) | View |
| 2019-10-11 08:02 am Purchase | 13G | FREQUENCY THERAPEUTICS INC FREQ | PERCEPTIVE ADVISORS LLC | 3,034,296 9.96% | 3,034,296 (New Position) | View |
| 2019-09-26 5:00 pm Purchase | 13D | VBI VACCINES, INC. VBIV | PERCEPTIVE ADVISORS LLC | 48,020,380 26.6% | 20,000,000 (+71.38%) | View |
| 2019-09-26 4:06 pm Purchase | 13G | SPRINGWORKS THERAPEUTICS INC C SWTX | PERCEPTIVE ADVISORS LLC | 3,217,522 7.4% | 3,217,522 (New Position) | View |
| 2019-09-25 5:09 pm Purchase | 13G | MEI PHARMA INC MEIP | PERCEPTIVE ADVISORS LLC | 6,600,660 8.7% | 2,200,220 (+50.00%) | View |
| 2019-08-20 5:01 pm Purchase | 13D | MEIRAGTX HLDGS PLC MGTX | PERCEPTIVE ADVISORS LLC | 6,448,737 17.6% | 425,531 (+7.06%) | View |
| 2019-08-06 4:27 pm Purchase | 13G | FOAMIX PHARMACEUTICALS LTD FOMX | PERCEPTIVE ADVISORS LLC | 11,203,881 18.4% | 6,542,057 (+140.33%) | View |
| 2019-07-11 5:00 pm Purchase | 13G | BRIDGEBIO PHARMA INC BBIO | PERCEPTIVE ADVISORS LLC | 6,586,268 5.5% | 6,586,268 (New Position) | View |
| 2019-07-02 10:30 am Purchase | 13G | ZYMEWORKS INC ZYME | PERCEPTIVE ADVISORS LLC | 2,349,147 6% | 2,349,147 (New Position) | View |
| 2019-06-24 5:00 pm Purchase | 13G | UROVANT SCIENCES LTD SHS UROV | PERCEPTIVE ADVISORS LLC | 1,598,277 5.3% | 1,598,277 (New Position) | View |
| 2019-06-20 4:34 pm Purchase | 13D | VBI VACCINES, INC. VBIV | PERCEPTIVE ADVISORS LLC | 28,020,380 28.1% | 2,320,117 (+9.03%) | View |
| 2019-05-29 08:32 am Purchase | 13G | IDEAYA BIOSCIENCES INC IDYA | PERCEPTIVE ADVISORS LLC | 1,341,484 6.9% | 1,341,484 (New Position) | View |
| 2019-05-28 08:31 am Purchase | 13G | ESTABLISHMENT LABS HLDGS INC C ESTA | PERCEPTIVE ADVISORS LLC | 1,260,528 6.2% | 646,286 (+105.22%) | View |
| 2019-05-23 08:31 am Purchase | 13G | ADMA BIOLOGICS INC ADMA | PERCEPTIVE ADVISORS LLC | 11,521,102 19.4% | 5,000,000 (+76.67%) | View |
| 2019-05-16 08:31 am Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | PERCEPTIVE ADVISORS LLC | 1,829,206 5.1% | 1,829,206 (New Position) | View |
| 2019-05-09 08:30 am Purchase | 13G | VIEWRAY INC VRAY | PERCEPTIVE ADVISORS LLC | 4,990,243 5.1% | 4,990,243 (New Position) | View |